Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SKRR Exploration Inc. V.SKRR

Alternate Symbol(s):  SKKRF

SKRR Exploration Inc. is a Canada-based precious metal explorer with properties in Saskatchewan mining jurisdictions. The Company's primary exploration focus is its three gold properties on the Trans-Hudson Corridor in Saskatchewan. The Company’s projects include Nickel Peak Group, Carp River, Manson Bay, Father Lake, Irving, Olson, Ithingo and Cathro. The Carp River property, comprised of five contiguous mineral claims totaling 5,606.48 hectares (ha), is located immediately north of the hamlet of Stony Rapids in the province of Saskatchewan. The 4,293 ha Manson Bay Project is located 40 kilometers (Km) northwest of Flin Flon, Manitoba’s historic mining center and four kilometers southwest of the Schotts Lake Copper-Zinc Deposit in Saskatchewan. The Father Lake property is located 40 km northeast of the hamlet of Stony Rapids in the province of Saskatchewan. The Ithingo Project consists of 12 contiguous mineral claims comprising an overall land package of approximately 2,849 hectares.


TSXV:SKRR - Post by User

Bullboard Posts
Post by DCArnoldon May 26, 2001 10:54pm
154 Views
Post# 3791369

AGM: Pat Pangburn's story

AGM: Pat Pangburn's storyAGM transcript: Pat Pangburn's story Dr. McPherson: I'd now like to introduce Pat Pangburn. Pat comes to us from Irving, Texas and she's going to have a few words to say. Pat? You don't need the notes? Pat Pangburn: I have my own, thank you. It's very nice to be here. Thank you Dr. McPherson, I appreciate it. I don't think I'm particularly unusual but apparently I guess I am. I think I'll tell you just a little bit about why I'm here and share with you some milestones when it comes to my health and what's going on with me. Eighteen months ago after almost seven years of being cancer free and cured of early stage breast cancer I was informed that the cancer had returned to my lung. I was grappling with some very sobering statistics mainly that women whose breast cancer has metastasized to a vital organ has no greater than a 2 to 3% chance of living for five years. I also found out that 50% of the women ever diagnosed with breast cancer will die from it eventually. Maybe not in two years, maybe not in five years but eventually it will die. I became and joined the ranks of the dirty little secret of breast cancer, which there is no cure. Fifteen months ago, I had just completed three months of chemotherapy, a weekly regimen, I had lost my hair, I had just lost my fingernails, had lost a little bit of my short term memory, that's why I have notes, I had lost my appetite but gained twenty pounds almost overnight and I'd broken a rib from incessant coughing that had been weakened from surgery, I'd lost half of a lung also. I felt like hell and I looked like hell and I was so exhausted but I couldn't sleep, probably because of insomnia caused by the cold, stark realization, the fear that I was a walking dead woman. I looked at my oncologist and she, much to her credit, treated me like an intelligent person that seemed to be aware of what was going on and she didn't mince words with me and she said 'I'll check you for recurrence, every three months, you'll have some blood work and you'll have a chest x-ray and go home and try to put your life back together.' I asked about clinical trials and all I got was a shrug, like there really isn't anything to do. I don't know, I've always sort of felt that there was always a plan B, there's always something out there that a person can try. So I immersed myself with the Internet and I really felt that this was the direction that I wanted to go. Then my oncologist quit her practice, so I really knew I was on my own. So I was able to find out about twelve months ago, saw a news release where there was a little biotech company in Canada that had been fast track approved for a cancer vaccine for metastatic breast cancer. I thought this sounds like something that might work for me and I remember clicking onto the NCI clinical trials site and reading the eligibility requirements about being in the trial. And it was like, I can remember it to this day, it was like winning the lottery, that each eligibility requirement was like a winning number. I kept saying 'Yep, I've got that one! I've got that one.' At the end I realized that it was perhaps better than winning the lottery. There was, at the bottom of this clinical trials site, there was a toll free number to call. I called Biomira and got a recorded message and I left my name and number and I was called within the hour. I was all set to go to the Hutchinson cancer center in Seattle, I just assumed that there was only one place where we had a clinical trial and as a matter of fact I had my choice, at that time, of two places in Texas; one being MD Anderson, in Houston and the other being Health Science Center in San Antonio. So I decided that San Antonio was where I needed to be, I have a daughter who lives there and I would always have transportation and a place to stay and could visit her at the same time. So I got on the telephone, called the study nurse, couldn't figure out why she didn't call me back, well she'd been on vacation, so I kept trying and that's something that I tell everybody who's ill that you do have to be your own advocate, you have to be the one that makes the initiative, takes the initiative and makes the calls because if you don't care about you nobody else will care about you. So we got together and nine months ago I met two very wonderful people. Helen Parker was the study nurse and Dr. Peter Ravdin, a brilliant research oncologist and principal investigator for this trial at the University of Texas Health Science Center in San Antonio. She was, Helen was the person that I called and I told her that I thought that I was eligible and we made an appointment and I went down to San Antonio and met with Dr. Ravdin. He's not only a brilliant and unbelievably kind man, he's extremely compassionate and his patients are so lucky to have him. And I knew I was in the right place, it just sort of felt good about being there and I really felt like I had been, the whole thing had changed, the whole picture of my health. This is a man who should probably never play poker because he kept looking at me like I was some alien, I was some foreign kind of entity and I finally said 'what is it?' and he said 'I just can't believe that you could find this trial and find your way here.' It had never happened, I didn't think that that was an unusual occurrence but apparently it is, it's not something that happens. Along those lines, when we talk about clinical trials, I have no idea if I'm getting the actual drug, vaccine or not. I have no idea whatsoever but the idea of being able to participate in a trial like this and you know I've got a 50% chance of being on it and it certainly was better than doing nothing. The idea of helping maybe my daughter's generation, she's 31 and this disease is finding its way to more and more young women and it needs to be, something needs to be done. We need a kinder, gentler treatment and hopefully that's what we'll find in Theratope. In the United States primary breast cancer, about 250,000 women a year are diagnosed with primary breast cancer and 50,000 are diagnosed with metastatic breast cancer but yet only 2-3%, well actually it's like under 5% of women who are eligible actually participate in clinical trials. I just find that reprehensible. We will never, ever beat back this disease unless more people participate and certainly more private practice doctors need to get their patients in clinical trials. I'd be remiss if I didn't mention that, something I'm very proud of, that I personally recruited six other women for this trial. This was done over the Internet and these were women who were also looking for hope and needed to have their attention called to the fact that this might be the kind of treatment that they could get. There are two women out there, Tina and Rebecca, who are on the trial, doing very well, healthy and everything seems to be fine and if I had a drink I'd toast to them right now. And then there are, I have to mention Pat from Chicago who's just barely hanging on but yet she started the trial and immediately recurred. I don't even think that she would be evaluable. And then there was another woman, Doris, who had the same thing happen and immediately went on to disease progression and she died. And then there's Milette and then there's Cheri who wanted on this trial so desperately but whose disease had gone too far and who are dead now and couldn't get on the trial. Eight months ago I decided to put my money where my mouth was and I became a stockholder and so I got a great thrill voting here with the rest of you. I just want you to know that I have no insider information because I bought high. I bought at $11 and then a couple weeks ago at $9.23. It makes me feel good to do that, to purchase the stock and be part of this company. Six months ago I attended the largest breast cancer conference in the United States, it's called the San Antonio Breast Cancer Symposium and it's like any other kind of, I guess you would call it a trade show, there are any number of booths around and you walk up and down and see the exhibits and everybody's got their gimme bags and their pencils and mouse pads. I looked up and I see in the distance a booth with the sign Biomira and I, of course, rushed over there and Bill Wickson was there, I think everybody knows Bill or if they don't, they should. Are you around Bill? There he is, in the back of the room. I went up to him and said 'Hi! I'm one of your lab rats.' And he thought I was a physician. He invited me to dinner that next night and I thought 'Wow! This is really nice to be in a clinical trial. They treat you well, they take you to dinner.' And this kind of thing and so it was, he told me that some other people from the company would be down and it was just absolutely delightful for me to meet them and it made me feel so good to know that, put faces with a company that probably had my life in their hands. I'm thrilled to have had that kind of contact with them. But it's such a pleasure to be here and to be able to say something nice about a company that is making a huge difference in my life, whether or not I'm getting the real vaccine or not, it's what it's done to me up here, the thought that I can hopefully do something. And I also want to say that one month ago I got clean scans and I am presently without evidence of disease. Thank you very much. Dr. McPherson: Thank you very much Pat and if the chemotherapy's had a bit of an effect on your short term memory because of the notes you have to, I wonder what it's done to me. Not so good. I don't even know where to start. End of second section
Bullboard Posts